Ravi Rao
Direktor/Vorstandsmitglied bei DBV TECHNOLOGIES
Aktive Positionen von Ravi Rao
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DBV TECHNOLOGIES | Direktor/Vorstandsmitglied | 19.05.2021 | - |
Independent Dir/Board Member | 19.05.2021 | - | |
AUTOLUS THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 01.04.2024 | - |
The Royal College of Physicians | Corporate Officer/Principal | - | - |
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01.04.2022 | - |
Karriereverlauf von Ravi Rao
Ehemalige bekannte Positionen von Ravi Rao
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Technik-/Wissenschafts-/F&E-Leiter | 18.08.2020 | 01.01.2022 |
SPYRE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 04.11.2019 | 10.08.2020 |
GSK PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2016 | 01.10.2019 |
Corporate Officer/Principal | 01.04.2012 | 01.09.2016 | |
OXFORD BIOMEDICA PLC | Corporate Officer/Principal | 01.03.2022 | - |
Ausbildung von Ravi Rao
University of Cambridge | Undergraduate Degree |
Imperial College London | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 8 |
Vereinigte Staaten | 2 |
Schweden | 2 |
Operativ
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 2 |
Sektoral
Health Technology | 8 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 6 |
---|---|
SPYRE THERAPEUTICS, INC. | Health Technology |
GSK PLC | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
DBV TECHNOLOGIES | Health Technology |
OXFORD BIOMEDICA PLC | Health Technology |
AUTOLUS THERAPEUTICS PLC | Health Technology |
Private Unternehmen | 1 |
---|---|
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Health Technology |